Dear readers of ADxS.org, please forgive the disruption.

ADxS.org needs about $53200 in 2024. In 2023 we received donations from third parties of about $ 32200. Unfortunately, 99.8% of our readers do not donate. If everyone who reads this request makes a small contribution, our fundraising campaign for 2024 would be over after a few days. This donation request is displayed 19,000 times a week, but only 40 people donate. If you find ADxS.org useful, please take a minute and support ADxS.org with your donation. Thank you!

Since 01.06.2021 ADxS.org is supported by the non-profit ADxS e.V..

$3391 of $53200 - as of 2024-02-01
6%
Header Image
Financial reports ADxS e.V

Financial reports ADxS e.V

ADxS e.V. is a recognized non-profit association.
ADxS e.V. is the sponsor of the website ADxS.org and the forum ADHS-Forum.adxs.org.

in 2022, ADxS e.V. received donations amounting to around EUR 13,000.
12.eUR 400 consisted of small donations of up to EUR 100.
ADxS e.V. does not accept donations from pharmaceutical companies.

2022 were spent (rounded amounts):
225 EUR Forum
14.900 EUR website, including for:
- Conversion from Wordpress to a self-built CMS
- Publication of the English language version

Board members and other members of the association did not receive any payments.

Although the required turnover was not achieved, a voluntary cash audit was decided on and carried out.
This resulted in: “Overall, the cash management is very clearly and comprehensibly documented and flawlessly managed.”

Development of readership figures in 2022:
ADxS.org from 17,650 unique readers / months in December 2021 to 45,500 unique readers in December 2022
ADHS-Forum.adxs.org from 6,844 unique readers in December 2021 to 20,000 unique readers in December 2022.

Diese Seite wurde am 19.01.2024 zuletzt aktualisiert.